|
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (USD $)
|
3 Months Ended |
6 Months Ended |
174 Months Ended |
|
Jun. 30, 2012
|
Jun. 30, 2011
|
Jun. 30, 2012
|
Jun. 30, 2011
|
Jun. 30, 2012
|
| Income Statement [Abstract] |
|
|
|
|
|
| Net sales |
$ 0 |
$ 0 |
$ 0 |
$ 0 |
$ 69,000 |
| Cost of goods sold |
0 |
0 |
0 |
0 |
24,120 |
| Gross profit |
0 |
0 |
0 |
0 |
44,880 |
| Operating expenses |
1,921,814 |
1,428,251 |
3,859,719 |
2,511,235 |
48,004,354 |
| Research and development expenses |
183,424 |
81,213 |
350,890 |
552,568 |
7,795,887 |
| Non-cash patent settlement cost |
0 |
0 |
0 |
0 |
1,610,066 |
| Loss before other income (expense) |
(2,105,238) |
(1,509,464) |
(4,210,609) |
(3,063,803) |
(57,365,427) |
| Other income (expense) |
2,384 |
(26,913) |
15,975 |
38,450 |
207,947 |
| Interest income |
0 |
0 |
0 |
0 |
16,342 |
| Interest and financing expense |
(351,422) |
(3,205,280) |
(2,814,289) |
(3,796,692) |
(19,490,906) |
| Change in fair value of derivative liabilities |
971,902 |
345,987 |
(167,575) |
1,563,584 |
1,960,626 |
| Gain on extinguishment of derivative liabilities |
85,576 |
0 |
85,576 |
0 |
85,576 |
| Costs of private placement |
0 |
0 |
0 |
0 |
(1,640,715) |
| Costs to induce conversion of notes |
0 |
0 |
0 |
0 |
(469,043) |
| Loss on disposition of equipment |
0 |
0 |
0 |
0 |
(14,426) |
| Settlement of Debt Due Morale/ Matthews |
0 |
0 |
0 |
0 |
(927,903) |
| Settlement of litigation and debt |
0 |
0 |
223,774 |
0 |
1,488,796 |
| Loss before provision for income taxes |
(1,396,798) |
(4,395,670) |
(6,867,148) |
(5,258,461) |
(76,149,133) |
| Provision for income taxes |
800 |
800 |
800 |
800 |
8,282 |
| Net loss |
$ (1,397,598) |
$ (4,396,470) |
$ (6,867,948) |
$ (5,259,261) |
$ (76,157,415) |
| Net loss per share, basic and diluted |
$ (0.01) |
$ (0.04) |
$ (0.06) |
$ (0.06) |
|
| Weighted average common shares outstanding,basic and diluted |
127,283,585 |
100,431,182 |
122,748,623 |
91,277,666 |
|